DOCSLIB.ORG

European Life Science Ceo Forum

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
European Life Science Ceo Forum WELCOME SPONSORS SPEAKERS PRESENTING COMPANIES 3rd Annual EUROPEAN LIFE SCIENCE CEO FORUM for PARTNERING & INVESTING AWARDS ORGANISATIONS PARTNERING 11-12 February 2010 ConventionPoint, Zurich, Switzerland Conference Guide REGIONAL PARTNERS ORGANISERS EUROPEAN LIFE SCIENCE CEO FORUM www.sachsforum.com WELCOME SPONSORS next Welcome Sachs Associates are delighted to welcome you to the: SPEAKERS PRESENTING COMPANIES 3rd Annual European Life Science CEO Forum for Partnering & Investing 11-12 February 2010 ConventionPoint, Zurich, Switzerland Sachs Associates are delighted to welcome you to the 3rd Annual European Life Science CEO Forum for Partnering & Investing. Following its success from previous years, the forum once again provides access to an exciting cross-section of venture-funded and small-cap companies with leading investors and pharmas. This exclusive and transactional event complements our Annual Biotech in Europe Investor Forum, held later in the year, but with added focus on Partnering & the pharmaceutical industry, feature presentations from Big Pharma representatives demonstrating their AWARDS ORGANISATIONS PARTNERING current and future partnering strategies through thought-provoking case studies. This year’s programme features a series of panels and presentations from leading investment, pharmaceutical and biotech companies, highlighting the current issues surrounding the evolving M&A market, Vaccines, Medtech Investment and includes special keynote speeches, providing an expert outlook on Europe’s Biotech industry. In addition, the event holds more than 50 company presentations from an exciting and diverse range of publicly listed and private life science companies, looking to raise fi nance and/or fi nd partners. This year’s DyoDelta Life Science Innovation Awards takes place in the evening of the 11th February and the awards recognise exceptional performance in key categories of partnering and fi nancing within the industry.. General Information • The registration desk is open from 8am on both days although you are welcome to join the event at any time. Please collect a copy of the agenda for information on timing and room allocation for REGIONAL PARTNERS ORGANISERS each session. • Coffee stations are distributed around the foyer and the presentation rooms throughout the event. • Wireless Internet connection is available throughout the venue for the duration of the event. Please ask for an access code at the registration desk. • The one-to-one meetings are being held in the Bid and Ask room. Please bring with you a copy of your diary. Should you have any queries about your schedule, the laptop situated by the meeting tables is available for your assistance. Request for Presentations Please use the agenda to mark off presentations that you are interested in and email your request to [email protected]. We will endeavour to send you the requested presentations as soon as we have been granted permission to do so by that specifi c presenter. Please note that we DO NOT have copies of the slides that are shown during the conference. WELCOME SPONSORS back Events Diary For regular updates, sponsorship, presenting and attending opportunities and further information regarding any of our future events please contact Rosa Lippard on [email protected] SPEAKERS PRESENTING COMPANIES 10th Annual Biotech In Europe Investor Forum 29 - 30 September 2010 • Radisson Blu Hotel • Zurich Airport Back for its 10th year, the Biotech in Europe Investor Forum will once again be held in Zurich, this year at the new venue, the Radisson Blu Hotel by Zurich Airport. Featuring our core sponsors, an audience of over 400 investors, analysts & media, with presenting opportunities for over 60 public and private companies and panel themes including Finance & Investment, Partnering and more, this event is a must for all key players in the Biotech and Pharma industry. The forum will be an excellent platform for companies to raise their profi le by promoting their interests to the larger fi nancial community. Facilitated by its successful one-on-one meeting system and networking receptions, the event will help build strong and meaningful business relationships through face to face communication, and promises to be a great opportunity to meet emerging AWARDS ORGANISATIONS PARTNERING companies, leading global investors, analysts, advisors and Big Pharma representatives. Panel discussions with participation from industry leaders and experts in their sector, makes the Biotech In Europe Investor Forum an excellent way to gain insight and keep up to date with partnering and investment and current industry trends. REGIONAL PARTNERS ORGANISERS WELCOME SPONSORS Host Sponsor SPONSORS next www.six-swiss-exchange.com SPEAKERS PRESENTING COMPANIES Europe’s leading exchange for life sciences companies Swiss fi nancial institutions manage more than one-quarter of the world’s offshore assets and represent the backbone of Switzerland’s strong fi nancial marketplace. As a result, companies listed on SIX Swiss Exchange achieve a high level of visibility within this fi nancially potent investor community. In Switzerland, the life sciences industry in particular has developed over the past years into an internationally recognised and strongly emphasized sectoral focal point: 1. In Europe, SIX Swiss Exchange has grown to become the most important securities exchange in terms of the total market capitalisation of listed life sciences companies: 42% of Europe’s life sciences market capitalisation is attributable to the SIX Swiss Exchange. 2. Collectively, these representatives of the industry account for roughly one-third of the overall market capitalisation of the Swiss equity market. 3. Listed companies in the life sciences fi eld such as Novartis, Roche and Actelion engender an environment that exudes global charisma. 4. Differentiated sector-specifi c indicators such as the SXI LIFE SCIENCES® and SXI Bio+Medtech® indices, as well as the unusually broad analyst coverage of this particular sector, ensure transparency and outstanding visibility. 5. The SIX Swiss Exchange has seen the largest biotech IPOs in Europe in terms of money raised on the AWARDS ORGANISATIONS PARTNERING day of the IPO every year since 2004 and was the only regulated exchange who recently attracted European biotech crossborder-IPOs. With a public offering of securities in Switzerland, and thanks to the tremendous placing power afforded by the Swiss-based investment banks, life science companies gain access to a sectorally experienced, highly competent and broadly international circle of investors. Moreover, the location-specifi c advantages of Switzerland and favourable general conditions contribute to the attractiveness of an initial public offering on the SIX Swiss Exchange: 1. The Continental European marketplace with the most pronounced international orientation 2. A leading fi nancial centre for equity-focused institutional investors 3. A strong private banking industry with a broad investor base 4. Multilingual and multicultural investors 5. Focus on life sciences and small- and mid-caps 6. Numerous banks with established in-house research departments 7. Active bond and derivatives markets 8. An attractive, market-oriented regulatory environment thanks to self-regulation 9. Acceptance of various accounting standards (US-GAAP, IFRS, Swiss GAAP ARR and additional internationally recognised standards) 10. Low foreign exchange risk (listing in various currencies is possible) REGIONAL PARTNERS ORGANISERS Further information on the topic of IPOs on the SIX Swiss Exchange can be accessed at: www.six-swiss-exchange.com/download/about/div_pub/swx_ipoguide_en.pdf Should you have further questions with regard to a public offering of securities, the various stock market segments or any other exchange-related topic, please feel free to contact our Issuer & Investor Relations team. SIX Swiss Exchange Issuer & Investor Relations Selnaustrasse 30, Postfach, CH-8021 Zürich T +41(0)58 854 22 45 F +41(0)58 854 22 40 WELCOME SPONSORS SPONSORS Sponsors back :: next DyoDelta Biosciences www.dyodelta.com SPEAKERS PRESENTING COMPANIES DyoDelta Biosciences Ltd., is a London based company specialising in providing Business Development and Due Diligence support to companies and investors in the Pharma / Biotech sector. DyoDelta Biosciences’ team averages more than 20 years experience per person and more than 150 years of cumulative experience. DyoDelta Biosciences has thousands of contacts at the senior corporate level worldwide and across the life sciences industry. The team’s executives have put together multiple types of deals, including R&D collaborations, strategic alliances, product licensing, acquisitions, disposals, fi nancings and local geography partnering, with NPVs adding to billions of dollars. DyoDelta Biosciences covers Europe, the US and Japan, in guiding and supporting pharma and biotech companies, investors, institutions and organisations in corporate transactions, evaluation and due diligence. Corporate deals with pharma companies are key to progressing development, providing funding, validation and also the trigger to investors for either an IPO or further funding. DyoDelta Biosciences provides support to professional investors (funds) in the pharma and biotech sector the following areas: • Market Research and Analysis • Identifi cation of suitable opportunities • Deal Sourcing • Industry Contacts AWARDS ORGANISATIONS PARTNERING • Commercial & Technical Evaluation • Due Diligence For more information,
Load more

Recommended publications
  • Innovation Hub for Life Sciences
    explore! page and and page Turn the the Turn Sciences Hub for Life Life for Hub is the the is Innovation Innovation Bio Science Park Park Science Bio Why Leiden Leiden Why 10 Reasons 10 Leiden Bio Science Park, the Innovation Hub for Life Sciences The leading Dutch Life Sciences & Health Innovation Hub in West Holland The park is situated in the West Holland region and is centrally located between Amsterdam and Rotterdam, in the economic heart of the Netherlands. With the upcoming relocation of the European Medicines Agency (EMA) in the surrounding area, it is time to seize the moment and settle in the fastest growing science park. Turnkey offices, dedicated laboratories and 300,000 square metres of green fields are at your disposal. Interested in setting up or expanding your activities at the Leiden Bio Science Park? Please contact us at: Leiden Bio Science Park BioPartner Center 2 2333 CH Leiden The Netherlands T: +31 (0) 71 5247555 E: offi[email protected] lbsp.nl lifesciencesinwestholland.nl 10 Reasons why Leiden Bio Science Park is the Innovation Hub for Life Sciences The Leiden Bio Science Park is the largest and most mature life sciences cluster in the Netherlands. Located at the park are over a 100 dedicated biomedical companies, including several multinationals such as Johnson & Johnson, Astellas and Galápagos. The park has the highest number of bioscience start-ups in the Netherlands providing a dynamic environment for the development of exciting novel therapeutics. This combination positions Leiden as a significant international ‘R&D hub’. INNOVATION 1 Among top 5 European Science Parks Leiden Bio Science Park is the number 1 Life Sciences & Health hotspot in The Netherlands and one of the most important clusters within Europe 2 10 educational institutes, a highly educated life sciences labor force Leiden Bio Science Park has a wide range of research and educational institutions, from top academic institutes, to PhDs & postdocs, and vocational level education.
    [Show full text]
  • Opens Innovation Hub in Leiden Bio Science Park
    GRÜNENTHAL GROUP Press Release Grünenthal's Innovative Medicines Unit (IMU) opens its first Innovation Hub to further strengthen the company’s networked Research and Development approach • The IMU – Leiden Hub will serve as Grünenthal’s European center for Open Innovation • Integration in scientific community of Leiden Bio Science Park, the Netherlands, enables easier access and close collaboration with leading scientists and institutions • At Leiden Bio Science Park, about 17,000 employees in biomedical companies, research institutions and hospitals are dedicated to the development of innovative drugs and solutions to support patients Aachen, Germany, and Leiden, the Netherlands, January 6, 2016 – The Grünenthal Group, an international, family-owned pharmaceutical company, announced today the opening of an Innovation Hub as an expansion of its Innovative Medicines Unit. The Hub will be located in Leiden, the Netherlands, and be embedded in the Leiden Bio Science Park, the largest cluster of biotech and pharmaceutical companies in the Netherlands and one of the five most successful science parks in Europe. The IMU – Leiden Hub will enable Grünenthal to engage even more strongly in networked research and development by building strong alliances and partnerships with academia, the biotech community and innovative service providers. The parties involved strive to jointly find solutions for patients suffering from illnesses with high unmet medical need and to bring these solutions faster to the patients by improving the “bench to bedside”-approach. Entrepreneurial and networked approach to R&D "We are excited to open the first hub of our Innovative Medicines Unit", says Dr. Klaus-Dieter Langner, Chief Scientific Officer of Grünenthal.
    [Show full text]
  • Hollandbio Business Solutions Member-To-Member Guide
    HollandBIO Business Solutions Member-to-Member Guide 2017 2 HollandBIO Business Solutions 3 Preface Though small in surface area, the Netherlands definitely is a major player in life sciences. The Dutch sector owes its success to an entrepreneurial spirit, a great scientific backbone, a remarkable talent to get stuff organized and a natural ability to cooperate. HollandBIO is the Dutch biotech industry association. We actively look after the sector’s interests and support a strong, more than willing to show starters the national and international network. ropes! In addition, the range of HollandBIO’s activities include advocacy, professional services tuned to the needs networking, national and international of life sciences companies is rapidly representation, as well as our HollandBIO increasing. Business Solutions: a range of services dedicated to supporting start-ups and This booklet proudly presents the 2017 SMEs. HollandBIO member companies. It is part of our Member-to-Member (M2M) HollandBIO strives to enable program, which helps biotech companies entrepreneurs to keep their eyes on the to build on the sector’s combined ball: to build a successful company knowledge and to gain insight in existing enabling society to profit from innovative services. And, HollandBIO members and valuable biotech products. Running a exclusively benefit from a number of company in life sciences is challenging. It attractive promotions! requires dedication, persistence and courage. The biotech world is highly Have a look what’s on offer! specialized and advice from biotech pioneers as well as professional service providers is essential to succeed. Annemiek Verkamman Fortunately, seasoned entrepreneurs are Managing Director HollandBIO Member-to-Member Guide 4 Content The HollandBIO members are listed in alphabetical order.
    [Show full text]
  • Business & Investment Opportunities in West Holland
    Business & Investment opportunities in West Holland Chris van Voorden Director Foreign Investments In this presentation 1 Content . About InnovationQuarter . The West Holland region . Strong economic sectors . Opportunities / invest & innovate in West Holland 2 About InnovationQuarter / invest & innovate in West Holland About InnovationQuarter 3 Shareholders . the Dutch Ministry of Economic Affairs and the Province of South-Holland . the municipalities of Delft, The Hague, Dordrecht, Leiden, Rotterdam & Westland . the three universities of Delft (University of Technology), Leiden & Erasmus Rotterdam and the two academic medical centers Erasmus MC & LUMC. / invest & innovate in West Holland Our tasks 4 We fund cutting edge and fast growing businesses with our own investment fund (InnovationQuarter Capital). We organize co-operation between innovative companies, knowledge institutions and government (InnovationQuarter Business Development). We assist foreign enterprises setting up their business in West Holland (InnovationQuarter Foreign Investments). / invest & innovate in West Holland 5 About the West Holland region / invest & innovate in West Holland About West-Holland 6 Facts about our region - 3.5 million inhabitants - 21 % of total GDP in The Netherlands - Port of Rotterdam, largest port in Europe - Three internationally highly rated universities - Many technological top institutes (TNO, ESA, Deltares) / invest & innovate in West Holland Key sectors in West Holland region 7 Clean Tech Life Safety & Sciences & Security Health IQ HortiCulture High Tech / Smart Industry / invest & innovate in West Holland About our region High Density of High Tech Systems & Materials 8 / invest & innovatie in West Holland 9 Life Sciences & Health / invest & innovate in West Holland InnovationQuarter 1 Life Sciences & Health 0 10 Medical Delta: West Holland LSH cluster . High Level business locations: .
    [Show full text]
  • Life Sciences Cluster Report
    Life Sciences Cluster Report Global | 2014 Global competition heats up as small and mid-tier companies dictate demand • Innovative leadership is recalibrating as emerging countries, particularly those in Asia, report impressive growth figures in patent applications, R&D funding, labor productivity and science degrees. • The demand environment has shifted from one driven by Big Pharma companies to one where mid-tier companies and specialty players are experiencing overnight growth and highly variable needs in response to promising products and treatments. JLL | Life Sciences Cluster Report | 2014 A message from Roger Humphrey Beyond the shifting demand among big and small industry players, we have also noticed the Roger Humphrey is the Executive Managing Director and changes in geographic activity and demand continuing over the past year. The United States and practice lead for the life sciences business at JLL. Roger Europe have enjoyed deep-seated roots as the leaders of high-value aspects of the development guides a team of more than 1,400 professionals dedicated to cycle, like new product research & development (R&D). In recent years, however, innovative developing customized solutions that help pharmaceutical leadership is recalibrating, with many developing nations making moves to grow their domestic and biotech companies reduce costs and boost productivity capabilities for innovation. Asian countries, led by Japan, Korea and China, have dramatically throughout their real estate and facilities portfolios. increased their share of patent applications and the number of doctorate and other higher education degrees awarded in science and engineering fields. The United States remains the dominant His background includes over 29 years in Commercial Real contributor of life sciences patent applications by a significant margin, but its year-on-year growth Estate and Facilities Management.
    [Show full text]
  • 2018 Press Information
    2018 PRESS INFORMATION Contents 1 General 4 2 Leiden - Key to Discovery 5 3 History 6 4 Waterways 7 5 Museums 8 6 Leiden's Inner City 11 7 Rembrandt van Rijn 12 8 Theatre 13 9 Monuments 14 10 Walks 18 11 Shopping 20 12 Music 21 13 Restaurants 22 14 Accessibility 23 15 Hotels 24 16 Leiden Congrescentrum (Conference Centre) 25 17 Leiden is a Significant Knowledge Centre 26 18 Did you know… 28 19 Leiden Tourist Information Centre 29 "Leiden - Key to Discovery" Leiden Marketing aims to emphasise the culture and knowledge pillars in order to present the city as an ideal destination for Dutch tourists, holiday makers and national or international knowledge workers looking for quality. Note to the Editor For further information: Mincke Pijpers Leiden Marketing Communications & PR Phone: 0031 71 51 60 993 Email: [email protected] Website: www.visitleiden.nl/en/contact/press Facebook: www.facebook.com/OntdekLeiden Twitter: www.twitter.com/OntdekLeiden Images Leiden Marketing has an online image bank from which you may download images copyright-free for editorial support of Leiden. Please do sent a mail to Mincke Pijpers for access to this gallery. 1 General Leiden is situated in the county of South-Holland, between The Hague and Amsterdam. The distance between Leiden and the North Sea coast is 12 kilometres. The historic compact city, which has lots of attractions within walking distance, links the Bulb Region and the Green Heart. Facts and Figures • 122,000 inhabitants • 30,000 students • 200 restaurants • 60 bars • 22 hotels • 3000 hotel
    [Show full text]
  • Leiden University Institutional Plan 2015-2020
    Freedom to Excel Leiden University Institutional Plan - February Content Introduction ................................................................................................. 3 Vision, mission & core values ...................................................................... 6 Societal and political context ....................................................................... 8 Six ambitions ................................................................................................ 11 1. An environment for excellent research ................................................... 11 2. Activating talent ....................................................................................... 14 3. Innovation in teaching and learning ....................................................... 18 4. Impact and innovation ............................................................................ 20 5. Research and teaching in an international environment ....................... 24 6. Campus The Hague .................................................................................. 27 People, resources and organisation ............................................................. 29 Introduction Focus on excellence Since its foundation in Leiden University has had a major influence both in the academic world and in society. From its earliest days, the University has been one of the world’s most international universities, attracting academics and students from all over Europe. The strength of this attraction is still evident
    [Show full text]
  • International.Org Business Destination Hollandholland Volume 3 - Nr2 - 2013 - Meetinginternational.Org
    Dit document wordt u aangeboden door: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX klik hier voor meer artikelen MeetingInternational.org Business Destination HollandHolland Volume 3 - nr2 - 2013 - MeetingInternational.org Find out why Holland should be your next MICE destination Discover the new Rijksmuseum - The Dutch Masters - Leiden, a city worth exploring - Hotel review: Sofitel Legend The Grand Amsterdam Pullman Eindhoven Cocagne: Make your meetings run extra smoothly With Co-Meeting by Pullman you benefit from personal support by our highly skilled Event and IT Solutions Managers as well as high-level technologies. Pioneering ideas are created not only in our 18 meeting rooms (for up to 400 people), but also during the innovative break-time activities that we offer. Pullman Eindhoven Cocagne, Vestdijk 47, Eindhoven 5611 CA, Netherlands. Book now at pullmanhotels.com or by telephone on: +31 (0) 40 - 2326160 Photographer: Hugo Potharst Photographer: Paris . Sao Paulo . London . Shanghai . Dubai . Bangkok . Sydney . Berlin . Bali . Barcelona JOIN OUR GLOBAL LOYALTY PROGRAM AT ACCORHOTELS.COM 2076_PM_AZ_Eindhoven_215x285_ENG_0913_k1.indd 1 05.09.13 13:32 Preface Meeting Pullman Eindhoven Cocagne: Make your meetings run extra smoothly With Co-Meeting by Pullman you benefit from personal support by our highly skilled Event and IT Solutions Managers as well as high-level technologies. Pioneering ideas are created not only in our 18 meeting rooms (for up to 400 people), but also during the innovative break-time activities that we offer. Pullman Eindhoven Cocagne, Vestdijk 47, Eindhoven 5611 CA, Netherlands. Book now at pullmanhotels.com or by telephone on: +31 (0) 40 - 2326160 Dutch art: world class Internationally, the Netherlands are leading in the field of art and history.
    [Show full text]
  • Focus on the Appliance of Science from LEIDEN Focus on the Appliance of Science from LEIDEN
    Focus on the Appliance of Science FROM LEIDEN Focus on the Appliance of Science FROM LEIDEN Colofon Texts Design With special thanks to everyone Esther Thole Ratio Design.nl interviewed in this book and: Ionica Smeets BioPartner Leiden Peter Baggen Editing Communications department LU Anke Klerkx, LURIS Communications department LUMC Pictures Aurélie Veltema, LURIS Ratio Design Aad van Vliet / TwoMoves Marilyn Hedges, Academisch Irene van der Plas Talencentrum Leiden Marc de Haan Sander Pardon The Appliance of Science Research is at the heart of the mission of both Medical Sciences in 1924. To this day the ECG is the Leiden University (LU) and Leiden University Medical best way to measure and diagnose abnormal rhythms Center (LUMC). It has been since the creation of of the heart and is still in use in hospitals all over. the University in 1575. However, it is not research solely for the sake of research but also so that LU In 2010, The World University Rankings by the Times and LUMC can play their roles in promoting clinical, Higher Education Supplement put Leiden University societal and economic development. This is ‘The equal first in the world in field of Industry income – Appliance of Science’. Innovation. This category is designed to cover an institution’s knowledge­transfer activity. It is Much of the research at LUMC is Translational determined by the institution’s research income Research, meaning that it has a close connection from industry scaled against the number of academic to clinical need. This ensures that the relevance of staff. An excellent performance from Leiden Univer­ the scientific research can be directly translated into sity and the Leiden University Medical Center.
    [Show full text]
  • Map of Leiden Bio Science Park
    6 A44 aallaan eg V erlengde elw erstraat t Wassenaarse a og Kag a r weg V t s Nachteg e l e o 1 p n Blauw ë ri a 4 enstraat 41 P a M Wassenaarse Sandifor v 62 g i 2 weg weg 61 u s we s t 75 Wassenaarse r 10 54 a 74 a elaan tdreef v Bohr Rijnsburg illem Einthov 7 t W ls Galileiw e 11 eg i 20 Hildebrandpad P 73 14 g 51 3 N 21 Boerhaa Robert Boyleweg we eg 22 erw eg 63 t Ende r 19 42 Kolffpad 55 12 w Dankmeijerpad 9 Verhaarpad52 eg I 8 Oo n ge Overweteringpad . 23 niusstraat 72 ge n H Galileiw esterwat Van Rijsselpad . AlbinusdreefHeur 15 Sylvius i g e J 43 H. u e r 13 18 53 Dunantw G Goliuspad w 24 31 P eg . n etering 64 71 e T 9 g ja r 25 oelw P l e e P tdreef P m 14 b rin n a i Einthov w Einsteinw T e eg Einsteinw g eg Bontiuspad elaan g eg 17 Sandifor Schuttersv Schiphol70w 57 66 Zer 50 Barg 9 edreef 30 nikedreef 56 enw Einsteinw nik 32 eld eg Zer 29 37 eg g 36 Hippocratespad 69 e w t 28 39 Station 68 s 15 49 e Leiden Centraal f 65 5 N206 n P N 38 Darwinw 58 e 33 eg r e 45 h weg wton 35 44 E Plesmanlaan 16 26 48 we 34 eg Pesthuislaan Stations g eg Rijnhof Archimedes Einsteinw 33 Mendelw Life sciences companies / organisations 46 47 67 27 33 w w 59 40 60 eg eg Leiden University Medical Center g e eg w w Plesmanlaan Leiden University u o el h Morssing c Schipholw S OtherA44 educational institutes e gs aa D H o Other companies / organisations c to r L e ly la a n N206 # 75 10x Genomics 17 Astellas 19 BioPartner Center Leiden building 2 69 Cell Signaling Technology Europe 8 20Med Therapeutics 3 Avery Dennison Europe (J.H.
    [Show full text]
  • Economic Impact of Leiden University and Leiden University Medical Center
    BiGGAR Economics Economic Impact of Leiden University and Leiden University Medical Center A report to Leiden University and Leiden University Medical Center August 2012 BiGGAR Economics Midlothian Innovation Centre Pentlandfield Roslin, Midlothian, EH25 9RE Scotland +44 (0)131 440 9032 [email protected] www.biggareconomics.co.uk CONTENTS Page 1 MAIN FINDINGS....................................................................................................1 2 EXECUTIVE SUMMARY .......................................................................................2 3 INTRODUCTION ...................................................................................................8 4 CORE IMPACTS .................................................................................................11 5 STUDENT IMPACTS...........................................................................................21 6 PROFESSIONAL SKILLS AND KNOWLEDGE .................................................29 7 INDUSTRIAL INVESTMENT ...............................................................................35 8 OUTPUTS FROM RESEARCH ...........................................................................44 9 TOURISM ............................................................................................................54 10 GRADUATE PREMIUM.....................................................................................65 11 SUMMARY ........................................................................................................67
    [Show full text]
  • 9780813810461.Pdf
    Nursing Care of the Hospitalized Older Patient Nursing Care of the Hospitalized Older Patient Edited by Terry Mahan Buttaro and Kate A. Barba A John Wiley & Sons, Inc., Publication This edition first published 2013 © 2013 by John Wiley & Sons, Inc Wiley-Blackwell is an imprint of John Wiley & Sons, formed by the merger of Wiley’s global Scientific, Technical and Medical business with Blackwell Publishing. Editorial Offices 2121 State Avenue, Ames, Iowa 50014-8300, USA The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 9600 Garsington Road, Oxford, OX4 2DQ, UK For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell. Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Blackwell Publishing, provided that the base fee is paid directly to the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license by CCC, a separate system of payments has been arranged. The fee codes for users of the Transactional Reporting Service are ISBN-13: 978-0-8138-1046-1/2013. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book.
    [Show full text]